AR 226_ 0646 PFOS Medical Surveillance/Epi - oL 000023 Internal Correspondence 3am -- EE--------g--------eee-- ree-- -------- August 2000 MemotoFilere: ~~ OUS pooled samples Pursuant to a reviewofmy file, there are raw data for several other pooled human sera sample results for PFOS dating from 1999.

AR 226 -- 0780 MICROBIAL INHIBITION (DEHYDROGENASE ACTIVITY TEST) IESTSuesTANCE Identity: ArefmeirxrteudretocaonstaPiFnOiSng,pFeCr-f9i5u,oroorocatsanaescuolmfponoanteen,twohficFhC-m2a0y6aolrsoL-be 3243. (1-Octanesulfonic acid) (CAS # 2795-39-3).

: AR 226 _ 08ST TOXICITY TO AQUATIC PLANTS IESTSUBS ~~ T0 A0 N0C 0E 0 Identity: A mixture containing perfluorooctanesulfonate, which may also be referred to as PFOS, FC-95, or as a component of FC-603EF.

250i7p ORIGINAL ~~ pr226- 095/ 3M Medical Deparment Study:T-6265.7 -_ LaboratRoerpy oRretquNeos.t FNAuCmbTeTrOUXz023705 ANALYTICAL LABORATORY REPORT FROMTHE 26-Week Capsule Toxicity Study with Perfluorooctanesulfonic Acid Potassium Salt (T-6295) in Cynomolgus Monkeys oNTHE Determination of the Presence and Concentration of Perfluorooctanesulfonate (PFOS) in Liver and Serum Samples Project Identification 3M Medical Department Study: T-6295.7 Covance In-Life Study: #6329-223 Analytical Study: FACT TOX-030 3M Laboratory Request No.

RYT ou5nsteezraOnsbovreanss ocmuteOberdorsrooche@stuerr>moen To enVelmneAGDuPon [A provided initially.

oo 0 = o 2 0 Sx 05 35 = =p = Eo aS a8 Q3s0 wd = AL226- 147 4 o &i:3 3 g 000041 =-- a ~ o Q & ~~ TM 3 oo Ec 5> oQ -o 28E o7a 0a er = Qc sesS <22 x Eosg - wc n OSs aLszN c53028 Q 335g Er a 0 Bs oo 32% c 3 Ss vo O 5E2 &88 g5e0g9e3l 2S3 = Oo =<=5 g3 eX R=8 c2 0 0 =8 S225 go QQ 3O So offx< 258 = 298C3c 55 E 83S58E5 Scs ECBc =S a wd wu 2 D2" 8s -- QL w5t T 5 u D s 2 XE 8s on =E 0 23 2S 0 S B2S28 S3 80 o8 m3 s5 a1 E0 Sx Segarra 53= 2 SwnES S - TTT G Exoa 7isiim s o 000042 g= e:= >S88 8Eg32 = 00 $pe < =f] ~|&f 18) 5_ 8 S2 i: S8E.S 2R5E EE Ey 2859553 3 E &g <o c 8 45 =2 8= 0Qo]H mn |] | | El = 2 , a=n| == = 8 LIE 8 | ~2 == ; 0000232 ErCoA7B10040105377 8Eg 5Ls 2wan gg @o 2 a Oo > c = L~ BEa Ts 8& 29 g 0 2 > 2Q 8Q 4 c 0 ~voETo --Q cwu 6 8SXE RoEo - 8 5 nw Eo > o =Bt cO= g 5 TO -= 25 S BE22os- 0 & _JgET -- O5o CS5e5E8 EcCaQS 8 S O 5 82Eso; Tc OO --- -- 2 S5 S 5c9v0 w PcDow o 28 8s SB al 2383 E2358 a3 o ET co gL 93 s <W OT >On | - Co 000024 cron camoo0srs 3 Hid = _-- -- Tf ` i 2 83 2s 1 $i: 2 2-- 1E --_-- =5] | |g | . 773 7 jo [{ 2 JJ JY Bn |4 ( / EE| Ebs ) i | One ERE E L WEE [ -- ={ A | |!

BACK TO MAIN PERFLUOROOCTANESULFONATE, POTASSIUM SALT (PFOS): A FLOW-THROUGH BIOCONCENTRATION TEST WITH THE BLUEGILL (Lepomis macrochirus) FINAL REPORT WILDLIFE INTERNATIONAL, LTD.

BACK TO MAIN STABILITY IN WATER (HYDROLYSIS) TEST SUBSTANCE Identity: Remarks: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, FC-116, FC-126, FC-169, or FC-143.

BACK TO MAIN BIODEGRADATION (BOD/COD) TEST SUBSTANCE Identity: Perfluorooctanesulfonylamido(ethyl)acetate; may also be referred to as PFOSAA, FC-128 or as the major component of FC-127, FC-129, FC-109, FC-109-X, FC-4351, or L-6778.

BACK TO MAIN CEntre Analytical Laboratories, Inc. 3048 Research Drive State College, PA 16801 www.centrelab.com (814) 231-8032 Fax: (814) 231-1253 or (814) 231-1580 Analytical Report Fluorochemical Characterization of POTW Effluent Port St.

Regulation (EC) No. 1907/2006 (REACH) Proposal for a restriction of Per- and polyfluoroalkyl substances (PFASs) submitted by BAuA - Federal Institute for Occupational Safety and Health Bureau REACH, National Institute for Public Health and the Environment (RIVM) Swedish Chemicals Agency (KEMI) Norwegian Environment Agency The Danish Environmental Protection Agency Date: 07.02.2023 22 March 2023 Dear Sir or Madam, We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFASs) according to Regulation (EC) No. 1907/2006 ("REACH").

iScience c Cellpress OPEN ACCESS Article Enteral liquid ventilation oxygenates a hypoxic pig model Tasuku Fujii, Yosuke Yoneyama, Akiko Kinebuchi, Hiroshi Date, Kimitoshi Nishiwaki, Takanori Takebe @cchmc.org Highlights Enteral liquid ventilation oxygenates independent of native lung function Early oxygen transfer dynamics inversely correlate with baseline oxygenation status Enteral liquid ventilation reduced the partial pressure of carbon dioxide Oxygenation commences from the venous outflow of the large bowel Fujii et al., iScience 26, 106142 March 17, 2023 2023 The Authors. https://doi.org/10.1016/ j.isci.2023.106142 iScience c CelPress OPEN ACCESS Enteral liquid ventilation oxygenates a hypoxic pig model Tasuku Fujii,1 Yosuke Yoneyama,2 Akiko Kinebuchi,2 Naoki Ozeki,3 Sho Maeda,1 Norikazu Saiki,2 Toyofumi Fengshi Chen-Yoshikawa,3 Hiroshi Date,4 Kimitoshi Nishiwaki,1 and Takanori Takebe2,5A7,8,* SUMMARY The potential of extrapulmonary ventilation pathways remains largely unexplored.

BACK TO MAIN Decomposition of Perfluorooctane Sulfonate by Combustion Processes Introduction To understand the potential degradation pathways for perfluorinated chemicals, it was necessary to model the thermodynamics of incineration processes.

AR226-1486 ENVIRONMENTAL AND HEALTH ASSESSMENT OF PERFLUOROOCTANE SULFONIC ACID AND ITS SALTS August 20, 2003 Prepared by 3M in consultation with Jack Moore, D.V.M., DABT, Hollyhouse, Inc.

!